All Type of News
“Obesity is ‘disease.’ Just change of lifestyle won’t work to cure”
‘Obesity’ is a condition of having excessive body fat. Due to change of dietary life and lifestyle after 1980, the world’s obesity rate was increased more than double; there are reportedly about 600 million people wit...
FIP Seoul Congress, event for world pharmacologists and pharmacists, opens
The ‘77th 2017 FIP World Congress of Pharmacy and Pharmaceutical Sciences,’ a grand festival for pharmacologists and pharmacists in the world, has opened in Seoul, South Korea.
On the subject of ‘Medicines and beyond...
Daehwa Pharmaceutical signs Chinese technology transfer agreement of ‘Liporaxel Soln’ for USD 25 million
Daehwa Pharmaceutical announced on the 6th that the company signed a technology transfer agreement of the world’s first approved oral paclitaxel anticancer drug(Korean product name: Liporaxel Soln) for USD 25 million ...
Dong Wha Pharm-GSK Consumer’s sale and supply agreement of OTC medicines
Dong Wha Pharm(CEO Ji-Hoon Sohn) held a sale and supply agreement ceremony of total 10 OTC medicines including the entire 7 OTC medicines owned by GSK Consumer Healthcare Korea and GSK Consumer Healthcare(GSK CH) at G...
3 listed pharmas showing danger signal in financial structure
Although most listed pharmaceutical companies were evaluated to have a sound financial structure, some pharmaceutical companies were criticized to show a danger signal on soundness of the financial structure.
Yakup S...
National Assembly Budgeting Office estimates KRW 27.8 billion a year for adopting public late-night pharmacies
The National Assembly Budgeting Office estimated average KRW 27.8 billion a year for adopting public late-night pharmacies.
The office recently revealed an expenditure estimation for the ‘Partial Revision Bill to the...
Strengthened health and medical cooperation between Korea and Russia
The Ministry of Health and Welfare(Minister Neung-Hoo Park, MOHW) visited Vladivostok, Russia to participate in the 3rd Eastern Economic Forum with the 16th Korea-Russia Joint Committee of Economy, Science and Technol...
Green Cross Cell creates stepping stones to attract investments and enter the U.S. market with Maryland
Green Cross Cell(Deuk-Joo Lee), a cell therapy company, announced on the 6th that the company signed a ‘memorandum of understanding(MOU) for promotion of investments’ with the Maryland state of the U.S.
Under the MOU...
Samsung Biologics will manufacture biologics on behalf of a European pharma
Samsung Biologics will manufacture biologics on behalf of a foreign pharmaceutical company.
Samsung Biologics announced on the 6th that the foreign company was a pharmaceutical company headquartered in Europe and it ...
Teva-Handok acquires approval of ‘CINQAIR,’ biologic for treatment of severe asthma patients
Teva-Handok(CEO Sun-Dong Park) announced that ‘CINQAIR(generic name: reslizumab),’ a new monoclonal antibody injection for the treatment of asthma, acquired approval from the Ministry of Food and Drug Safety on the 4t...
